Supplementary Fig. S8 from FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors

Authors: Roberta Bianchi, Leo Kunz, Ralf J. Hosse et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>Schematic detailing and results from the in vivo study with MCA205 tumor model treated with FAP-LTBR and anti-PDL1 in monotherapy and in combination.</p></jats:p>

Keywords

pschematic detailing results from vivo

Supplementary Fig. S8 from FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors

Abstract

Keywords

Related Articles

Precipitation processes in an Antarctic moist air intrusion: insights from multi-frequency radar observations over a 1100-km transect

Sustainable Ammonia Production from Biogas: A Review

Gendered Language and Technology Adoption by Small-Scale Producers: Evidence from a Choice Experiment in India

The Naples Prognostic Score Predicts Long-Term Outcomes in Critically Ill Patients with First Acute Myocardial Infarction: A Retrospective Cohort Study from the MIMIC-IV 3.2 Database

Figure 4 from DNA Methyltransferase Inhibition Prevents Platinum-Induced Ovarian Cancer Stem Cell Enrichment